Antecedent therapy versus detection bias as causes of neoplastic multimorbidity

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 1, 1999, Pages 51-56

  Craig, Steven L ^a   Feinstein, Alvan R ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bias; Detection; Multimorbidity; Neoplasia; Statistics

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; DIAGNOSTIC ACCURACY; HUMAN; METASTASIS; MORBIDITY; MULTIPLE CANCER; SECOND CANCER; STATISTICAL ANALYSIS;

BIAS (EPIDEMIOLOGY); HUMANS; MORBIDITY; NEOPLASMS; NEOPLASMS, SECOND PRIMARY;

EID: 0033508080     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199902000-00013     Document Type: Article

References (23)

1. Billroth CAT. Die allgmeine chirurgische pathologie and therapie. 14 Aufl. Berlin: G. Reimer. 1989;908.
2. Schottenfeld D. Multiple primary cancers. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996;1370-87.
3. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. American Journal of Cancer 1932;16:1358-414.
4. Tucker MA, Meadows AR, Boice JD Jr, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987;78:459-64.
5. Hoover RN. Cancer induced by cancer treatment. In: Fortner JF, Rhoads JE. eds. Accomplishments in cancer research 1992, general motors cancer research foundation. Philadelphia: J B Lippincott, 1993.
6. Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone-marrow transplantation. N Engl J Med 1997;336:897-904.
7. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: W B Saunders, 1985;332-3.
8. Bugher JC. The probability of the chance occurrence of multiple malignant neoplasms. American Journal of Cancer 1934; 21:809-24.
9. Kobayashi Y, Aximoto H, Ono I, Watanabe S. Multiple primary cancer in patients with initial laryngeal cancer. Jpn J Clin Oncol 1900;20:128-33.
10. Miyaguchi M, Sahai S, Mori N, Kitaoku S. Multiple primary malignancies in patients with malignant tumours of the nasal cavities paranasal sinuses. J Laryngol Otol 1990;104:696-8.
11. Tarbell NJ, Gelber RD, Weinstein HJ, Mauch P. Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 1993;341:1428-32.
12. Tucker MA. Secondary cancers. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer principles and prevention. Philadelphia: J B Lippincott, 1993;2407-16.
13. Percy D, Young JL, Muir C, et al. Introduction. Cancer 1995;75(suppl):140-6.
14. Fisher B, Constatino JP, Redmond CK, et al. Endometnal cancer in tamoxifen-treated breast cancer patients: findings from the national surgical adjuvant breast and bowel projects (NSABP) B-14. J Natl Cancer Inst 1994;86:527-37.
15. MacFarlane MJ, Feinstein AR, Wells CK, Chan CK. The 'epidemiologic necropsy'. unexpected detections, demographic selections, and changing rates of lung cancer. JAMA 1987;258:331-8.
16. Koss LG, Schreiber K, Oberlander SG, Moussouris HF, Lesser M. Detections of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol 1984;64:1-11.
17. Horwitz RI, Horwitz SM, Feinstein AR, Robboy SJ. Necropsy diagnosis of endometrial cancer and detections-bias in case-control studies. Lancet 1981;2:66-8.
18. van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994;12:1063-73.
19. Brada M, Ford D, Ashley S, et al. Risk of second brain tumour after conservation surgery and radiotherapy for pituitary adenoma. BMJ 1992;304:1343-6.
20. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.
21. Tsang RW, Laperriere NJ, Simpson WJ, et al. Glioma arising after radiation therapy for pituitary adenoma, a report of four patients and estimation of risk. Cancer 1993;72:2227-33.
22. Chan CK, Joseph BR, Wells CK, Feinstein AR. An analysis of gastric and oesophageal cancers found with 'epidemiological necropsy' during 1953-1982. Int J Epidemiol 1989;18:315-9.
23. Fossa SD, Langmark F, Aass N, et al. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990;61:639-43.